Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Environmental Monitoring in Cleanrooms

Posted on By

SOP for Environmental Monitoring in Cleanrooms

Procedure for Environmental Monitoring in Cleanrooms

1) Purpose

The purpose of this SOP is to outline the procedure for conducting environmental monitoring in cleanrooms to assess air quality and microbial contamination levels.

2) Scope

This SOP applies to all cleanrooms within the facility where pharmaceutical products are manufactured, requiring routine environmental monitoring to maintain compliance with regulatory standards and internal specifications.

3) Responsibilities

Quality Assurance (QA) Department: Responsible for overseeing environmental monitoring activities.
Environmental Monitoring Team: Responsible for conducting sampling and analysis according to this SOP.

4) Procedure

4.1 Monitoring Points Selection:
    4.1.1 Identify critical monitoring points (e.g., active air sampling, surface sampling) based on cleanroom classification and risk assessment.
    4.1.2 Ensure sampling points represent different zones within the cleanroom (e.g., critical, controlled, support).

See also  In-Process Control: SOP for Elemental Impurity Testing

4.2 Sampling Methods:
    4.2.1 Prepare sampling equipment, including agar plates, air samplers, and swabs, following sterilization and calibration procedures.
    4.2.2 Perform active air sampling using calibrated equipment at predetermined flow rates and durations.
    4.2.3 Conduct surface sampling by swabbing predefined areas using validated techniques and media.

4.3 Sample Collection:
    4.3.1 Execute sampling activities in aseptic conditions to avoid contamination.
    4.3.2 Record environmental conditions (e.g., temperature, humidity) at the time of sampling.
    4.3.3 Label samples with unique identifiers, including location, date, and

time of collection.

4.4 Analysis and Incubation:
    4.4.1 Transport samples to the microbiology laboratory promptly for analysis.
    4.4.2 Incubate agar plates and swabs according to specified conditions (e.g., temperature, duration) to promote microbial growth.
    4.4.3 Monitor plates for colony formation and record observations regularly.

See also  SOPĀ for Density Testing

4.5 Data Interpretation:
    4.5.1 Count and identify microbial colonies using validated methods and identification techniques.
    4.5.2 Compare results against predefined alert and action limits for microbial contamination.
    4.5.3 Investigate any deviations from acceptable limits and implement corrective actions.

4.6 Reporting:
    4.6.1 Document all monitoring activities, including sampling procedures, results, and corrective actions, in the Environmental Monitoring Report.
    4.6.2 Provide summary reports to QA for review and approval.
    4.6.3 Archive all records according to facility procedures and regulatory requirements.

5) Abbreviations, if any

QA: Quality Assurance

6) Documents, if any

Environmental Monitoring Report
Calibration Records for Monitoring Equipment
Microbial Identification Records

See also  SOP for Granulation Size Distribution

7) Reference, if any

ISO 14644-1:2015 – Cleanrooms and associated controlled environments
FDA Guidance for Industry – Sterile Drug Products Produced by Aseptic Processing

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Supplier Qualification and Approval
Next Post: SOP for Supplier Performance Monitoring

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version